Poisoning is an indication for drug development with over 60 pipeline drugs currently active. According to GlobalData, preregistered drugs for Poisoning have a 87.5% likelihood of approval (LoA) indication benchmark. GlobalData’s report assesses how phase transition success rate (PTSR) and likelihood of approval (LoA) scores for pipeline drugs in Poisoning compared to historical benchmarks. Buy the report here.
Smarter leaders trust GlobalData
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
Poisoning overview
A poison refers to any substance harmful to the body, whether ingested, inhaled, injected, or absorbed through the skin. Excessive intake of any substance can render it poisonous. Examples of poisons encompass prescription or over-the-counter medications taken in high doses, illegal drug overdoses, carbon monoxide from gas appliances, household items like laundry powder or furniture polish, pesticides, indoor or outdoor plants, and metals such as lead and mercury. The consequences of poisoning vary from brief illness to severe outcomes like brain damage, coma, or fatality. Prevention involves strict adherence to product labels, storing items securely away from children, and treatment depends on the specific poison involved.
For a complete picture of PTSR and LoA scores for drugs in Poisoning, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Likelihood of Approval analytics tool dynamically assesses and predicts how likely a drug will move to the next stage in clinical development (PTSR), as well as how likely the drug will be approved (LoA). This is based on a combination of machine learning and a proprietary algorithm to process data points from various databases found on GlobalData’s Pharmaceutical Intelligence Center.
